Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Real world validation

Real world validation of an innovation can bring benefits to both industry and health and care.

It can help with the adoption and spread of an innovation, providing potential adopting organisations with an understanding of the implementation pathway and assurance of benefit delivery.

Alongside this, real world validation can support industry to generate investment and enhance a product’s sales story to enable growth and job creation. Real world validation is an observed study to assess the impact and benefits to patients, staff and the health economy, in a non-controlled environment, of an innovation that has already undergone a pilot process.

All real world validation projects aim to capture:

  • Validation of the claimed benefits of the innovation
  • Patient uptake and satisfaction with the innovation
  • Staff uptake and satisfaction with the innovation and any associated changes in working practice
  • Identification of challenges of the innovation implementation process (and their solutions)
  • Costs associated with the innovation implementation process
  • Financial impact on the organisation, the NHS, and the wider health economy

UCLPartners runs its real world validation process in partnership with the innovator and a health or social care organisation.

All parties work together to deliver a real world validation report at the end of the process to answer the relevant points above. The final real world validation report is then shared with the 15 AHSN organisations in the AHSN network to promote the adoption and spread of the innovation in question. The report is intended to add to the innovation story and serve as a guide to implementation for other organisations that may wish to adopt it.

For more information contact Chris Wood.